Health Care & Life Sciences » Biotechnology | Proteon Therapeutics Inc.

Proteon Therapeutics Inc.

Proteon Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.14
Market Cap
$8.25 M
Shares Outstanding
19.59 M
Public Float
7.85 M

Profile

Address
200 West Street
Waltham Massachusetts 02451
United States
Employees -
Website http://www.proteontherapeutics.com
Updated 07/08/2019
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F.

Financials

View All
Created with Highcharts 5.0.14Proteon Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.7 9127 9123 3423 34221 37721 37728 52628 52629 96429 96420 72920 72920132014201520162017201805k10k15k20k25k30k35k
Created with Highcharts 5.0.14Proteon Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.002 9482 9480000001151152013201420152016201720180500100015002000250030003500

Timothy P. Noyes
President, Chief Executive Officer & Director
Paul J. Hastings
Chairman